Case Study: Looking into the big picture – How to carve a more prominent space for market access between the medical and commercial?

Session

Looking into the big picture – How to carve a more prominent space for market access between the medical and commercial?

Case Study

Monday, October 07

09:00 AM - 09:30 AM

Live in Berlin

Less Details

The Market Access department is encountering a myriad of challenges in today’s dynamic landscape. Navigating the complexities of regulatory upheaval, we need to become more adaptable to maximize the market penetration. Add to it the evolving demands of payers and healthcare providers, who increasingly scrutinize the value proposition of the medicines. Balancing cost-effectiveness with innovative offerings poses a continual dilemma, especially amidst escalating healthcare costs and budget constraints. Furthermore, the rapid digitalization of healthcare systems introduces new hurdles in data management, privacy concerns, and ensuring seamless integration with various stakeholders. Overcoming these challenges requires agility, collaboration, and strategic foresight to secure optimal market access and sustain competitive advantage in an ever-changing landscape. How can we navigate this labyrinth and thrive?

In this presentation you will learn:

Between scientific and commercial – how can we be the most successful as a function?
The convergence of innovation and Market access – how can we bring innovative therapies to patients in need faster?
Navigating complex market landscapes – what are successful strategies to enable patient access to transformative therapies while ensuring sustainable healthcare systems?
Fostering Collaboration – how to ensure smooth collaboration between key stakeholders in the company to maximize patient impact?

Access Strategy

Market Access Strategy

Presentation

Speaker

Arup Pramanik

Corporate Vice President, Head of Global Market Access TA Inflammation, Boehringer Ingelheim

• Motivated and resourceful Commerical leader with significant Market Access, Global Product Strategy, Health Economics Outcomes Research, HTA, Marketing, Medical Affairs, and Pricing Strategy with country, regional and global experience.
• Built and managed Commercial, Value & Access and HTA capabilities, in 3 multinational pharmaceuticals now 4th with oversight on US & Global Market Access, Pricing, Global Product Strategy, Medical Affair’s and HEOR in Oncology, Rare Diseases, CardioVascular and Neuroscience franchises
• Recognized for developing teams and implementing locally tailored patient access and pricing solutions working seamlessly with country operations by appreciating the constraints of their Healthcare Financing, Clinical evidence, and Health Economic /HTA within the framework of their health care delivery system
• 18 year of professional and leadership experience having consistently lead and built high-performance teams who have delivered high double-digit growth in competitive environments
• Recognized for integrating payer insights, scientific, humanistic and real-world evidence with reimbursement strategy in mind
• Known for ability to connect with external stakeholders in academic, policy and Government to build on value proposition and integrate shared value engagements and solutions
• Recipient of 2 Presidents Award for Innovative access & customer solutions and an emerging growth market regional award for customer partnerships
• Contributing member of Novartis Corporate, Pfizer , Shire and Boehringer Ingelheim Global Strategy team, defining new models, to ensure alignment with Governments, NGOs, and Patients to support sustainable access and Accountable member of Leadership Team tasked with reporting to Corporate Enterprise and Board of Directors

Join Arup Pramanik
Book Now!

Company

Boehringer Ingelheim

http://www.boehringer-ingelheim.com

Together with over 56,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals.

Get Agenda

Book Now